Pacer Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $982K | Sell |
8,337
-2,132
| -20% | -$298K | ﹤0.01% | 1219 |
|
|
2025
Q4 | $1.72M | Buy |
10,469
+256
| +3% | +$40.1K | ﹤0.01% | 1184 |
|
|
2025
Q3 | $1.37M | Buy |
10,213
+7,694
| +305% | +$935K | ﹤0.01% | 1269 |
|
|
2025
Q2 | $313K | Sell |
2,519
-397
| -14% | -$50.5K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $371K | Sell |
2,916
-8,867
| -75% | -$1.36M | ﹤0.01% | 1587 |
|
|
2024
Q4 | $1.7M | Sell |
11,783
-505
| -4% | -$72.4K | ﹤0.01% | 1092 |
|
|
2024
Q3 | $1.83M | Sell |
12,288
-574
| -4% | -$82.3K | ﹤0.01% | 1036 |
|
|
2024
Q2 | $1.62M | Buy |
12,862
+1,808
| +16% | +$283K | ﹤0.01% | 1036 |
|
|
2024
Q1 | $2.03M | Buy |
11,054
+241
| +2% | +$45.9K | ﹤0.01% | 845 |
|
|
2023
Q4 | $1.94M | Buy |
10,813
+4,308
| +66% | +$671K | 0.01% | 794 |
|
|
2023
Q3 | $1.03M | Sell |
6,505
-6,209
| -49% | -$1.01M | ﹤0.01% | 803 |
|
|
2023
Q2 | $1.8M | Buy |
12,714
+9,604
| +309% | +$1.54M | 0.01% | 768 |
|
|
2023
Q1 | $524K | Sell |
3,110
-6,784
| -69% | -$1.21M | ﹤0.01% | 1115 |
|
|
2022
Q4 | $1.68M | Buy |
9,894
+6,307
| +176% | +$1.14M | 0.01% | 605 |
|
|
2022
Q3 | $671K | Buy |
3,587
+3,210
| +851% | +$677K | ﹤0.01% | 652 |
|
|
2022
Q2 | $61K | Sell |
377
-874
| -70% | -$138K | ﹤0.01% | 2083 |
|
|
2022
Q1 | $235K | Sell |
1,251
-6,342
| -84% | -$1.2M | ﹤0.01% | 2072 |
|
|
2021
Q4 | $2.01M | Buy |
7,593
+483
| +7% | +$130K | 0.02% | 791 |
|
|
2021
Q3 | $2.06M | Sell |
7,110
-80
| -1% | -$20.5K | 0.03% | 661 |
|
|
2021
Q2 | $1.44M | Buy |
7,190
+1,657
| +30% | +$321K | 0.02% | 711 |
|
|
2021
Q1 | $1.08M | Buy |
5,533
+230
| +4% | +$47.2K | 0.02% | 740 |
|
|
2020
Q4 | $1.02M | Sell |
5,303
-6,166
| -54% | -$1.12M | 0.02% | 689 |
|
|
2020
Q3 | $1.69M | Buy |
11,469
+11,355
| +9,961% | +$1.62M | 0.04% | 476 |
|
|
2020
Q2 | $14K | Hold |
114
| – | – | ﹤0.01% | 901 |
|
|
2020
Q1 | $12K | Sell |
114
-15,803
| -99% | -$1.53M | ﹤0.01% | 611 |
|
|
2019
Q4 | $1.47M | Sell |
15,917
-917
| -5% | -$77K | 0.07% | 399 |
|
|
2019
Q3 | $1.29M | Buy |
+16,834
| New | +$1.47M | 0.03% | 720 |
|
|
2018
Q4 | – | Sell |
-2,099
| Closed | -$116K | – | 935 |
|
|
2018
Q3 | $116K | Buy |
+2,099
| New | +$108K | ﹤0.01% | 1074 |
|
|
2018
Q1 | – | Sell |
-725
| Closed | -$26K | – | 1111 |
|
|
2017
Q4 | $26K | Buy |
+725
| New | +$26.2K | ﹤0.01% | 1083 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
Pacer Advisors's RGEN Position: Q1 2026 in Review
Pacer Advisors reduced its Repligen (RGEN) stake by 20% in Q1 2026, selling an estimated $298K and leaving 8,337 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #1219.
Pacer Advisors first reported a position in RGEN in Q4 2017 and has held it in 29 quarters since. The position peaked at $2.06M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Pacer Advisors held 8,337 shares of Repligen worth $982K as of Q1 2026.
- Pacer Advisors sold 2,132 Repligen shares in Q1 2026, an estimated $298K.
- Repligen made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1219 holding.
- Pacer Advisors first reported a position in Repligen in Q4 2017 and has held it in 29 quarters since.
- Pacer Advisors's Repligen position peaked at $2.06M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.